Why watching the World Cup is easier than managing a portfolio, what happens if Synchrony loses Walmart and why soybean price matter. Read More

How dollar cost averaging can help reduce risk in your portfolio. How bad is the soybean tariff news for the Farm Belt and why biotech stocks were so strong last week. Read More

Pulling apart Lindsay Corp's backlog, and why it matters.  Analysts boost Steven Madden and Tapestry and more. Read More

A primer on how Profit Catalyst Alert works options into the mix of trade suggestions. Also, in defense of Steelcase, which got whacked unfairly, and why I like Chemours so much. Read More

Rising estimates support the increased price targets on Systemax and Carbonite but PRA Health must be sold on valuation. I'll be watching this quality player in the healthcare space for a better entry point in the future. Also, Ichor continues to droop- what will send the shares higher? Read More

Tearing apart the bullish and bearish arguments on Ichor took some time but all looks well in the end. Bulls and bears battled it out on Steven Madden and the truckers report smooth shipment data. Read More

The bears reigned last week as Dollar General and Big Lots delivered poor results. New regulations benefit Chemours and more... Read More

Why I still like Target despite a slight miss in earnings, what's in store for Big Lots this week and truckers getting a boost. Our weekly roundup. Read More

Both the Walmart and Abbvie options trades worked out well for subscribers. A bit more on how these trade suggestions should work and what's on the calendar moving forward. Carbonite continues to deliver good news and why Air Transport Services lumbers along. Read More

Harsco's surge in demand began even before the government's policy changes on aluminum and steel and what Abbvie's Dutch tender means for investors. Read More